PRNP and prion disease: In addition, we demonstrate that mPPIg5 does not interfere with the biogenesis or processing of the regular PrP isoform, indicating that modified dendrimers possess significant potential as anti-prion therapeutics and as agents for investigating the nature of prion diseases.